Sodium Channel

钠通道 (Sodium Channel) 是形成离子通道的膜内蛋白,可将钠离子 (Na+) 传导通过细胞的质膜。根据打开此类离子通道的触发因素,可对钠通道进行分类,即电压变化(电压门控、电压敏感或电压依赖性钠通道,也称为 VGSC 或 Nav 通道)或物质(配体)与通道的结合(配体门控钠通道)。在可兴奋细胞(如神经元、肌细胞和某些类型的神经胶质细胞)中,钠通道负责动作电位的上升阶段。电压门控 Na+ 通道可以存在于三种不同状态中的任何一种:失活(关闭)、激活(打开)或失活(关闭)。配体门控钠通道通过配体的结合而不是膜电位的变化来激活。

Sodium channels are integral membrane proteins that form ion channels, conducting sodium ions (Na+) through a cell's plasma membrane. They are classified according to the trigger that opens the channel for such ions, i.e. either a voltage-change (Voltage-gated, voltage-sensitive, or voltage-dependent sodium channel also called VGSCs or Nav channel) or a binding of a substance (a ligand) to the channel (ligand-gated sodium channels). In excitable cells such as neurons, myocytes, and certain types of glia, sodium channels are responsible for the rising phase of action potentials. Voltage-gated Na+ channels can exist in any of three distinct states: deactivated (closed), activated (open), or inactivated (closed). Ligand-gated sodium channels are activated by binding of a ligand instead of a change in membrane potential.

共 5种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(R)-Eslicarbazepine acetate
(R)-利卡西平乙酸酯; BIA 2-059; (R)-Licarbazepine acetate

(R)-Eslicarbazepine acetate (BIA 2-059) 是 Eslicarbazepine acetate (MS-X22556) 的 R-对映体,而 Eslicarbazepine acetate 是一种抗癫痫剂,可作为 β-分泌酶和电压门控钠通道的双重抑制剂。

186694-45-1
Control
(R)-利卡西平乙酸酯
Anticonvulsant agent 7

Anticonvulsant agent 7 是一种具有口服活性的广谱抗惊厥剂,其作用不依赖于对 Na⁺/Ca²⁺ 通道的直接阻断,可用于惊厥研究。

Control
Anticonvulsant agent 7
Lamotrigine N2-Oxide

Lamotrigine N2-Oxide 是抗惊厥剂 Lamotrigine (MS-Z81446) 的代谢产物。

136565-76-9
Control
Lamotrigine N2-Oxide
N-Hydroxy riluzole
N-羟基利鲁唑

N-Hydroxy riluzole 是抗谷氨酸剂 Riluzole (MS-V48905) 的代谢产物。

179070-90-7
Control
N-羟基利鲁唑
(Rac)-Atomoxetine hydrochloride
(Rac)-Tomoxetine hydrochloride; (Rac)-LY 139603

(Rac)-Atomoxetine hydrochloride ((Rac)-Tomoxetine (hydrochloride); (Rac)-LY 139603) 是 Atomoxetine hydrochloride (MS-G04957) 的外消旋体,而 Atomoxetine hydrochloride 是一种选择性去甲肾上腺素再摄取抑制剂,对去甲肾上腺素 (NE)、5-羟色胺 (5-HT) 和多巴胺 (DA) 转运体的 Ki 值分别为 5、77 和 1451 nM,可通过增加 PFC 中 DAEX 和 NEEX 来增强儿茶酚胺能神经传递,同时也是一种有效的 Na+ 通道阻断剂 (VGSCs),可用于注意力缺陷多动障碍 (ADHD) 的研究。

82857-40-7
Control
外消旋盐酸托莫西汀杂质1;托莫西汀杂质1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础